验证中国的健康相关结果措施-心血管疾病
Xue Li1, Rui Li2, Feiyi Xiao3
1Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada; Department of Health Technology Assessment, China National Health Development Research Center, Beijing, Beijing, China.
概括
中国健康相关结果测量心血管疾病 (CHROME-CVD) 仪器显示出用于评估中国心血管疾病患者健康状况的良好的心理测量特性. 建议对修改后的仪器进行进一步验证.
科学领域:
- 健康 结果 研究 研究 结果
- 心理测量 心理测量 心理测量
- 心血管疾病流行病学
背景情况:
- 中国健康相关成果措施 (CHROME) 倡议为中国开发了基于偏好的生活质量工具.
- 染色体心血管疾病 (CVD) 是一个专门为心血管疾病患者设计的14项仪器.
研究的目的:
- 在中国人群中评估CHROME-CVD仪器的心理测量特性.
- 评估CHROME-CVD用于测量心血管疾病患者与健康相关的生活质量的可靠性和有效性.
主要方法:
- 一项横截面问卷调查,涉及6个中国省份444名患有各种心血管疾病的患者.
- 使用经典测试理论 (项目评估,内部一致性,可靠性,有效性) 和项目响应理论的心理测试评估.
- 与EQ-5D-5L和特定疾病的非偏好型仪器进行比较.
主要成果:
- 探索性因子分析确定了四个因素:胸痛,其他症状,身体健康和心理/社会健康.
- 观察到高的内部一致性 (克朗巴赫α>0.8) 和测试复试可靠性 (ICC>0.8).
- 收性和歧视性有效性假设在很大程度上得到满足 (分别为76.9%和94.7%),没有显著的子组差异.
结论:
- 该CHROME-CVD仪表表现出在评估中国心血管疾病患者与健康有关的生活质量方面具有良好的心理测量特性.
- 根据分析,对项目响应选项和措辞进行了修改.
- 进一步验证改进的CHROME-CVD仪器是有必要的.
相关概念视频
Assessment of the Cardiovascular System I: Subjective Data
343
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
343
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
93
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
93
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
159
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
159
Errors occurring during blood pressure monitoring
730
Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
Several factors...
730


